Combined AFP-CRUT with microvascular invasion accurately predicts mortality risk in patients with hepatocellular carcinoma following curative liver resection

References

• Ferenci P, Fried M, Labrecque D, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol 2010;44(4):239-45
   PubMed Web of Science ®Google Scholar
• Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreatic Dis Int 2008;7(3):237-57
   PubMed Web of Science ®Google Scholar
• Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235(3):373-82
   PubMed Web of Science ®Google Scholar
• Du ZG, Wei YG, Chen KF, Li B. Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patients. Hepatobiliary Pancreatic Dis Int 2014;13(2):153-61
   PubMed Web of Science ®Google Scholar
• Wang YX, Liu H. Adult hepatoblastoma: systemic review of the English literature. Dig Surg 2012;29(4):323-30
   PubMed Web of Science ®Google Scholar
• Abelev GI, Perova SD, Khramkova NI, et al. Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1963;1:174-80
   PubMed Web of Science ®Google Scholar
• Gillespie JR, Uversky VN. Structure and function of alpha-fetoprotein: a biophysical overview. Biochim Biophys Acta 2000;1480(1-2):41-56
   PubMed Web of Science ®Google Scholar
• Terentiev AA, Moldogazieva NT. Alpha-fetoprotein: a renaissance. Tumour Boil 2013;34(4):2075-91
   PubMedGoogle Scholar
• Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27(1):273-8
   PubMed Web of Science ®Google Scholar
• Zhu WJ, Huang CY, Li C, et al. Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection. Asian Pac J Cancer Prev 2013;14(12):7101-6
   PubMedGoogle Scholar
• Masuzaki R, Karp SJ, Omata M. New serum markers of hepatocellular carcinoma. Semin Oncol 2012;39(4):434-9
   PubMed Web of Science ®Google Scholar
• Zhang XF, Lai EC, Kang XY, et al. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection. Ann Surg Oncol 2011;18(8):2218-23
   PubMed Web of Science ®Google Scholar
• Paul SB, Gulati MS, Sreenivas V, et al. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein. Oncology 2007;72(Suppl 1):117-23
   PubMed Web of Science ®Google Scholar
• Farinati F, Marino D, De Giorgio M, et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 2006;101(3):524-32
   PubMed Web of Science ®Google Scholar
• Chu CW, Hwang SJ, Luo JC, et al. Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C. J Clin Gastroenterol 2001;32(3):240-4
   PubMed Web of Science ®Google Scholar
• Szabó BK, Kristoffersen-Wiberg M. Dynamic MR imaging as a predictor of prognosis in breast cancer. J Spec 2006;20(1):19-28
   Web of Science ®Google Scholar
• Bone B, Szabo BK, Perbeck LG, et al. Can contrast-enhanced MR imaging predict survival in breast cancer? Acta Radiol 2003;44(4):373-8
   PubMed Web of Science ®Google Scholar
• Wilbaux M, Henin E, Oza A, et al. Dynamic modeling in ovarian cancer: an original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development. Gynecol Oncol 2014;133(3):460-6
   PubMed Web of Science ®Google Scholar
• Yu C, Kastin AJ, Ding Y, Pan W. Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Exp Neurol 2007;203(1):116-22
   PubMed Web of Science ®Google Scholar
• Pinato DJ, Karamanakos G, Arizumi T, et al. Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study. Aliment pharmacol Ther 2014
   PubMed Web of Science ®Google Scholar
• Vibert E, Azoulay D, Hoti E, et al. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 2010;10(1):129-37
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. Journal Clin Oncol 2002;20(6):1527-36
   PubMed Web of Science ®Google Scholar
• Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009;29(4):502-10
   PubMed Web of Science ®Google Scholar
• Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999;30(4):889-93
   PubMed Web of Science ®Google Scholar
• Ebara M, Ohto M, Kondo F. Strategy for early diagnosis of hepatocellular carcinoma (HCC). Ann Acad Med Singapore 1989;18(1):83-9
   PubMedGoogle Scholar
• Nguyen MH, Garcia RT, Simpson PW, et al. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002;36(2):410-17
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132(7):2557-76
   PubMed Web of Science ®Google Scholar
• Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89(3):500-7
   PubMed Web of Science ®Google Scholar
• Chaiteerakij R, Addissie BD, Roberts LR. Update on Biomarkers of Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2013;13(2):237-45
   PubMed Web of Science ®Google Scholar
• You Z, Chen LP, Ye H. Predictors of microvascular invasion in patients with solitary small hepatitis B related hepatocellular carcinoma. Pak J Med Sci 2014;30(2):331-4
   PubMed Web of Science ®Google Scholar
• Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 2011;254(1):108-13
   PubMed Web of Science ®Google Scholar
• Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008;15(5):1375-82
   PubMed Web of Science ®Google Scholar